|
Sep 30
|
CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP
|
|
Sep 27
|
3 ASX Growth Companies With Insider Ownership Up To 22%
|
|
Jul 5
|
Clinuvel Pharmaceuticals Leads Three High Growth Companies With Significant Insider Ownership
|
|
Jun 18
|
Afamelanotide in fair-skinned Parkinson’s patients
|
|
Nov 27
|
Clinuvel Pharmaceuticals Limited's (ASX:CUV) largest shareholders are retail investors with 59% ownership, institutions own 20%
|